z-logo
open-access-imgOpen Access
Nasal carriage of Methicillin- and Mupirocin-resistant S. aureusamong health care workers in a tertiary care hospital
Author(s) -
Loveleena Agarwal,
Amit Kumar Singh,
Chandrim Sengupta,
Anjali Agarwal
Publication year - 2015
Publication title -
journal of research in pharmacy practice
Language(s) - English
Resource type - Journals
eISSN - 2319-9644
pISSN - 2279-042X
DOI - 10.4103/2279-042x.167046
Subject(s) - mupirocin , medicine , cefoxitin , methicillin resistant staphylococcus aureus , staphylococcus aureus , linezolid , carriage , antibiotics , microbiology and biotechnology , vancomycin , bacteria , pathology , biology , genetics
Methicillin-resistant Staphylococcus aureus (MRSA) ranks top among the nosocomial pathogens. Nasal formulation of mupirocin is found to eradicate MRSA from colonized individuals, but the emergence of resistant strains is a matter of concern.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here